Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomaides

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Antimicrobial Agents and Chemotherapy|September 18, 2013
Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerasesNeil R Stokes, Helena B Thomaides-Brears, Stephanie Barker, et al.
Journal of the Royal Society of Medicine|February 14, 2023
Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort studyAndrea Dennis, Daniel J Cuthbertson, Dan Wootton, et al.
The Journal of Biological Chemistry|September 22, 2005
Novel inhibitors of bacterial cytokinesis identified by a cell-based antibiotic screening assayNeil R Stokes, Jörg Sievers, Stephanie Barker, et al.
Frontiers in Immunology|February 2, 2018
<i>Salmonella</i> Typhi Bactericidal Antibodies Reduce Disease Severity but Do Not Protect against Typhoid Fever in a Controlled Human Infection ModelHelene B Juel, Helena B Thomaides-Brears, Thomas C Darton, et al.
Scientific Reports|October 31, 2024
Liver magnetic resonance imaging, non-alcoholic fatty liver disease and metabolic syndrome risk in pre-pubertal Mexican boysBenito de Celis Alonso, Elizabeth Shumbayawonda, Cayden Beyer, et al.
BMC Infectious Diseases|July 4, 2026
Characteristics of Streptococcus pneumoniae colonising Cypriot children during a period of high PCV10 and PCV13 vaccine coverage: serotypes and antimicrobial resistanceGavriella Ioannou Vassiliadou, Petros Ladas, Michail Mendris, et al.
Bioorganic & Medicinal Chemistry Letters|December 10, 2008
Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZLloyd G Czaplewski, Ian Collins, E Andrew Boyd, et al.
Heart Rhythm|April 25, 2026
Safety and performance of a novel ICD lead for left bundle branch area pacing: Results from the ASCEND CSP trialRobert D Schaller, Prashanthan Sanders, Jacqueline Joza, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2008
DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: synthesis and antibacterial activityStephen P East, Clara Bantry White, Oliver Barker, et al.
Plos Neglected Tropical Diseases|October 20, 2020
Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection modelMalick M Gibani, Celina Jin, Sonu Shrestha, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Antimicrobial Agents and Chemotherapy|September 18, 2013
Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerasesNeil R Stokes, Helena B Thomaides-Brears, Stephanie Barker, et al.
Journal of the Royal Society of Medicine|February 14, 2023
Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort studyAndrea Dennis, Daniel J Cuthbertson, Dan Wootton, et al.
The Journal of Biological Chemistry|September 22, 2005
Novel inhibitors of bacterial cytokinesis identified by a cell-based antibiotic screening assayNeil R Stokes, Jörg Sievers, Stephanie Barker, et al.
Frontiers in Immunology|February 2, 2018
<i>Salmonella</i> Typhi Bactericidal Antibodies Reduce Disease Severity but Do Not Protect against Typhoid Fever in a Controlled Human Infection ModelHelene B Juel, Helena B Thomaides-Brears, Thomas C Darton, et al.
Scientific Reports|October 31, 2024
Liver magnetic resonance imaging, non-alcoholic fatty liver disease and metabolic syndrome risk in pre-pubertal Mexican boysBenito de Celis Alonso, Elizabeth Shumbayawonda, Cayden Beyer, et al.
BMC Infectious Diseases|July 4, 2026
Characteristics of Streptococcus pneumoniae colonising Cypriot children during a period of high PCV10 and PCV13 vaccine coverage: serotypes and antimicrobial resistanceGavriella Ioannou Vassiliadou, Petros Ladas, Michail Mendris, et al.
Bioorganic & Medicinal Chemistry Letters|December 10, 2008
Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZLloyd G Czaplewski, Ian Collins, E Andrew Boyd, et al.
Heart Rhythm|April 25, 2026
Safety and performance of a novel ICD lead for left bundle branch area pacing: Results from the ASCEND CSP trialRobert D Schaller, Prashanthan Sanders, Jacqueline Joza, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2008
DNA gyrase (GyrB)/topoisomerase IV (ParE) inhibitors: synthesis and antibacterial activityStephen P East, Clara Bantry White, Oliver Barker, et al.
Plos Neglected Tropical Diseases|October 20, 2020
Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection modelMalick M Gibani, Celina Jin, Sonu Shrestha, et al.
Pageof 13